The invention relates to the use of a compound of the formula (I)
##STR00001##
or a pharmaceutically acceptable addition salt thereof for the preparation
of a medicament for the prophylaxis and/or treatment of muscular
dystrophies or myopathies resulting from mutations in genes encoding for
collagen VI.